Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a phase IV, prospective, single-center, open-label, randomized, controlled study.
Eligible patients are randomly assigned into three groups. The investigators propose to
evaluate and compare the efficacy and safety of different neoadjuvant chemotherapies in women
with primary breast cancer.